key: cord-0312170-e8nndnn4
authors: Zhou, Jie; Sukhova, Ksenia; McKay, Paul F.; Kurshan, Ashwini; Yau, Yeuk; Lechmere, Thomas; Brown, Jonathan C.; Moshe, Maya; Kugasathan, Ruthiran; Snell, Luke B.; Edgeworth, Jonathan D.; Shattock, Robin J.; Doores, Katie J.; Peacock, Thomas P.; Barclay, Wendy S.
title: Omicron breakthrough infections in vaccinated or previously infected hamsters
date: 2022-05-20
journal: bioRxiv
DOI: 10.1101/2022.05.20.492779
sha: 3dbcb8b6af5475897138105416ee852dc1c92c21
doc_id: 312170
cord_uid: e8nndnn4

The second and third years of the SARS-CoV-2 pandemic have been marked by the repeated emergence and replacement of ‘variants’ with genetic and phenotypic distance from the ancestral strains, the most recent examples being Delta and Omicron. Here we describe a hamster contact exposure challenge model to assess protection conferred by vaccination or prior infection against re-infection. We found that 2-doses of self-amplifying RNA vaccine based on the ancestral spike ameliorated weight loss following Delta infection and decreased viral loads, but had minimal effect on Omicron/BA.1 infection. Prior infection with ancestral or Alpha variant was partially protective against Omicron/BA.1 infection, whereas all animals previously infected with Delta and exposed to Omicron became infected, although shed less virus. We further tested whether prior infection with Omicron/BA.1 protected from re-infection with Delta or Omicron/BA.2. Omicron/BA.1 was protective against Omicron/BA.2, but not Delta reinfection, again showing Delta and Omicron have a very large antigenic distance. Indeed, cross-neutralisation assays with human antisera from otherwise immunonaïve individuals (unvaccinated and no known prior infection), confirmed a large antigenic distance between Delta and Omicron. Prior vaccination followed by Omicron or Delta breakthrough infection led to a higher degree of cross-reactivity to all tested variants. To conclude, cohorts whose only immune experience of COVID is Omicron/BA.1 infection may be particularly vulnerable to future circulation of Delta or Delta-like derivatives. In contrast, repeated exposure to antigenically distinct spikes, via infection and or vaccination drives a more cross-reactive immune response, both in hamsters and people. One Sentence Summary Infection with the Delta and Omicron SARS-CoV-2 variants do not provide cross-protective immunity against reinfection with one another in hamsters.

the animals lost weight following the reinfection with BA.1 variant regardless of previous 146 SARS-CoV-2 infections, including the previously mock infected ones ( fig. S4 ). 147 We also tested the potential of the reinfected animals for onwards transmission by 148 measuring infectious virus exhaled through airborne droplets emitted by the infected animals 149 ( fig. S5 ). At day 2 following the exposure to the infected donor animals, the 4 naïve sentinels 150 and the 4 previous Delta infected hamsters were placed in a chamber from which air was 151 passed over the surface of susceptible cultured cells. Following 10 minutes of exposure, the 152 cells were removed and an overlay applied before 3 day incubation in order to observe 153 plaques formed by infectious virus deposited on the cells. Cell culture plates were placed at 3 154 different distances, 30 cm, 60 cm or 90 cm from the infected animal. All 8 infected hamsters 155 emitted virus into the air,, and overall plaque counts were not significantly different when 156 comparing those from the naïve sentinels and ones from the animals previously infected with previously infected animals at 6 weeks post-infection showed high neutralizing titres against BA.1, two sentinels showed relatively high neutralizing titres against BA.2 Spike, the rest 171 had low or non-detectable titres against BA.2 or Delta Spike (Fig. 3A) . Donor hamsters 172 infected with Delta variant lost weight as seen previously while donors infected with BA.2 173 did not lose weight, similar to the BA.1-infected donors described previously (Fig. 3B) . The 174 viral load in nasal washes of BA.2 infected hamsters was lower than that of Delta infected 175 donors fig. S6A -C). All 4 Delta-exposed animals were reinfected and shed 176 robust viral E gene loads and infectious virus in nasal washes (Fig. 3E and fig. S6C ). 3 of the 177 4 Naïve age-matched sentinel hamsters exposed to the BA.2 donors were infected, and virus 178 shedding became detectable in their nasal wash samples with a one day delay comparing to 179 the kinetics of transmission measured for BA.1 (see Fig. 2E ) (Fig. 3C and fig. S6A ). antibody responses in humans, we collected and tested the neutralisation activity of antisera 193 from hospitalised individuals taken during the first UK SARS-CoV-2 wave (N=9), the Alpha wave (N=9), the Delta wave (N=12) and the BA.1 wave (N=16) (Fig. 4) . Where possible we 195 chose sera from previously naïve, unvaccinated individuals whose only known exposure was 196 to the named variant. Sera was collected 13-24 days post onset of symptoms. All infected 197 individuals produced a robust neutralizing response against the strain they were initially 198 infected with. Cross-neutralization of other variants was observed but always at reduced titres 199 compared to homologous virus. In sera from first wave, Alpha or Delta infected individuals, Delta and BA.2 respectively were determined in comparison to that against BA.1. These data 206 highlight greater antigenic distance between Omicron and previous variants of concern and 207 also a considerable antigenic distance between BA.1 and BA.2 in otherwise naïve 208 individuals. 209 We also measured neutralizing antibody titres in individuals who experienced SARS- (Table 1) . Moreover, hamsters previously infected with pre-Omicron 228 variants can be re-infected with Omicron (Table 1) 90cm Naive sentinels exposed to BA.1 Delta sentinels exposed to BA.1

Naïve sentinels exposed to BA.1 donor WT/D614G sentinels exposed to BA.1 donor Alpha sentinels exposed To BA.1 donor Delta sentinels exposed to BA.1 donor Virus shedding profile of saRNA sentinels exposed to the delta donors. (C) Virus shedding profile of saRNA sentinels exposed to the BA.1 donors. Nasal wash samples were collected daily and assessed by real-time RT-PCR targeting Envelop gene of SARS-CoV-2. The lower detection limit is 1200 E copies/mL. Statistically significant differences were determined using Mann-Whitney test. * p<0.05. Naive S1 Naive S2 Naive S3 Naive S4

Naïve sentinels Pre-WT/D614G sentinels Pre-Alpha sentinels Pre-Delta sentinels Airflow is generated using a bias flow pump, which connects to a hamster chamber (10cm x 9cm, long x diameter). The chamber is connected to a half cylindrical clear acrylic 100cm (length) x 18cm (width) x 9cm (height) exposure tunnel containing cell culture plates situated 30cm, 60cm and 90cm from the animal. 

Total virus shedding of the donor and self-amplifying RNA vaccine (saRNA)

A) Area under the curve (AUC) of donor hamsters inoculated with 100

PFU Delta or BA.1 was determined by plaque assay or real-time RT-PCR. (B) AUC of 638 saRNA sentinels exposed to the delta donors. (C) AUC of saRNA sentinels exposed to the 639

Statistically significant differences were determined using Mannassessed by real-time RT-PCR targeting E gene of SARS-CoV-2. The lower detection limit is 651 1200 E gene copies/mL